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Abstract 
Aims: Sacrococcygeal teratomas are rare tumors that occur most frequently in neonates, although 
adult cases also occur. Molecular pathogenesis of these tumors and long term outcome is 
uncertain.  
Methods and results: Fifty four sacrococcygeal teratoma specimens from 52 patients were 
identified and available follow up information was obtained.  Fluorescent in situ hybridization 
analysis was performed to identify i(12p) abnormalities on paraffin blocks of the tumor. Among 
the 48 pediatric patients, there were 44 teratomas and 4 tumors with teratoma and yolk sac tumor 
(1 of which also had primitive neuroectodermal tumor). The teratomas included 37 mature 
teratomas and 11 immature teratomas (4 grade 1, 2 grade 2, and 5 grade 3). The 44 teratomas 
lacking a yolk sac tumor component were all negative for i(12p). The 4 tumors with a yolk sac 
tumor component were all positive for i(12p). The 4 adult cases all lacked nonteratomatous germ 
cell tumor components, immature elements, and i(12p). Follow up information was available for 
32 patients. Two patients with teratoma had recurrence, but were alive with no evidence of 
disease after long-term follow up. One patient with teratoma and yolk sac tumor had recurrence 7 
months after resection. The other patients were alive with no evidence of disease at last follow 
up.  
Conclusions: Our data suggest that pediatric sacrococcygeal teratomas should be considered as 
two distinct groups with a divergent histogenetic pathway. Prognosis of these tumors are 
excellent, despite rare recurrence.  
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Introduction 
Extragonadal germ cell tumors (GCTs) are rare tumors and accounting for 1-6% of all 
GCT cases.
1-5
 Extragonadal GCTs are thought to arise from germ cell precursors that remain 
along paths of embryonic migration and form tumors in the sacrococcygeal region, 
retroperitoneum, mediastinum, or other sites. 
4
 Although the morphologic appearances are 
analogous to those in the gonads, the frequency of GCT types and patient distribution are 
different. The most common extragonadal GCT location in adults is the mediastinum, whereas 
the sacrococcygeal region and central nervous system are more common sites in children.
6-10
 The 
behavior is dependent on the combination of patient age, histology type, anatomic site, and 
clinical stage.
4
 
Pediatric sacrococcygeal teratomas most often occur in neonates. Benign behavior is 
observed in most cases, although metastatic disease has been reported in a fraction of cases. The 
presence of immature elements in neonatal teratoma is not associated with malignant behavior, 
but the presence of a nonteratomatous component (yolk sac tumor and/or embryonal carcinoma) 
is considered evidence of malignant potential and an indication for three-agent cisplatin-based 
chemotherapy,
11, 12
 although patients with α-fetoprotein and β-human chorionic gonadotropin 
measurements that return to normal following surgery have been followed without chemotherapy 
(“watch and wait” approach) by some groups.
13-15
   In the absence of nonteratomatous elements, 
local recurrence may occur, but up to 100% long term survival has been described in 
sacrococcygeal teratomas, even in the presence of immature teratoma.
16
  Very rare 
sacrococcygeal teratomas may recur as YST, but this may represent inadequate histologic 
sampling of the primary tumor.
17, 18
 Sacrococcygeal tumors with a yolk sac tumor component 
have, even when metastatic, a relatively good prognosis with chemotherapy.
13, 15
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 Adult sacrococcygeal teratomas are very rare, with fewer data regarding prognosis, but 
the surgical treatment of adult sacrococcygeal teratoma has recently been discussed.
19
 Metastasis 
was observed in 3 patients in a series of 26 cases (12%), exclusively in women.
19
 Associated 
somatic-type malignancies are associated with poor prognosis.
19, 20
 Somatic-type carcinomas 
include adenocarcinoma, adenosquamous carcinoma, and low-grade neuroendocrine 
carcinoma.
19
 
 The isochromosome 12p abnormality is typical of postpubertal testicular germ cell 
tumors, but is lacking in germ cell lesions with expected benign behavior, such as pediatric 
testicular teratoma and ovarian mature cystic teratoma. Malignant GCTs in postpubertal patients, 
regardless of location, often have isochromosome i(12p).
21-26
 However, the same genetic 
abnormality is extremely rare in pediatric cases, even those with yolk sac tumor.
21, 27, 28
 Instead, 
the genetic alterations in malignant GCTs of prepubertal patients are frequently gains of 
chromosomes 1q, 3, or 20q and loss of chromosomes 1p, 4q, or 6q.
29-31
  
Sacrococcygeal teratoma is the most common GCT of neonates and rarely occurs in 
adults, 
16, 20, 32, 33
 yet studies of their i(12p) status are extremely limited except for one recent 
study.
16
 We investigated the i(12p) status of a large number of primary sacrococcygeal teratomas 
in both children and adults, including cases with malignant germ cell tumor elements (primitive 
neuroectodermal tumor and yolk sac tumor).  
 
Materials and Methods 
A computer-based text search of the surgical pathology files of Indiana University was 
conducted for “sacrococcygeal” and “teratoma” from 1990 to 2014, and we identified all 
specimens with paraffin blocks permitting the investigation of chromosomal 12p abnormalities 
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by fluorescence in situ hybridization (FISH). These included 4 specimens from adult patients and 
50 specimens from 48 pediatric patients. Clinical information including patient sex, age, duration 
of available follow up, and patient status at last follow up was obtained. All hematoxylin and 
eosin-stained sections of the tumors were reviewed by two pathologists (CK and LC) to confirm 
the diagnosis of teratoma and evaluate the following: histologic grade of teratoma using the same 
grading system as that used for ovarian teratomas and presence of malignant GCT.
34, 35
  
FISH testing was performed as previously described.
36
 The slides were deparaffinized 
with two 15-minute washes of xylene, followed by two 10-minute washes of absolute alcohol. 
The slides were then air-dried in a fume hood. The slides were treated in 0.1 mM citric acid (pH 
6.0; Zymed, Carlsbad, CA) at 95°C for 10 min, rinsed in distilled water for 3 min, and washed 
with 2 x SSC for 5 min. Digestion of the tissue was performed by applying 0.4 ml of pepsin 
(5mg/ml in 0.01 N HCl in 0.9% NaCl) (Sigma, St Louis, MO) at 37°C for 40 min. The slides 
were rinsed with distilled water for 3 min, and washed again with 2 x SSC for 5 min, and then 
air-dried. Dual color FISH was performed by using a mixture of Spectrum Orange labeled 
centromeric alpha satellite DNA probe (CEP12) and green labeled RP11-267D19 5-Fluorescein 
(12p11.21) DNA probes for chromosome 12p. Both of the probes were from Vysis (Downers 
Grove, IL) and were diluted with tDenHyb2 (Insitus, Albuquerque, NM) in a ratio of 1:50 and 
1:20, respectively. Five microliters of diluted probes were added to the slide in the reduced light 
condition, slides were covered with a coverslip, and were sealed with rubber cement. 
Denaturation was achieved by incubating the slides at 75°C for 10 minutes in a humidified box, 
then the slides were hybridized at 37°C overnight. The coverslips were removed and the slides 
were washed extensively twice with 45°C prewarmed 0.1X SSC/1.5 mol/L urea, for 20 minutes 
for each, followed by a wash with 2X SSC for 20 minutes and 2X SSC/0.1% NP40 for 10 
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minutes at 45°C. The slides were further washed with room temperature 2X SSC for 5 minutes. 
The slides were air-dried and counterstained with 10 µL of 4,6-diamidino-2-phenylindole (DAPI 
AntifadeInsitus). The slides were covered and sealed with nail polish. The slides were examined 
using a Zeiss Axioplan 2 microscope with the following filters: SP-100 DAPI, FITC MF-101 for 
Spectrum Green (12p) and Gold 31003 for Spectrum Orange (CEP12) from Chroma 
(Brattleboro, VT). The images were acquired with a CCD camera and analyzed with 
MetaSystem Isis software (Belmont, MA). Five sequential focus stacks with 0.4-µm intervals 
were acquired and then integrated into a single image in order to reduce thickness-related 
artifacts. From each tumor section, 100 nuclei were scored for signals from CEP12 (red) and 12p 
(green) under the fluorescence microscope with 1,000X magnification, and the ratio between 
green and red signals was subsequently calculated. We analyzed the spatial distribution of the 
green and red signals to detect the specific patterns of signal aggregation consistent with i(12p), 
as previously reported.
37
 The quantitative criteria to determine 12p overrepresentation have been 
described previously.
37
 A classical seminoma specimen was used as a positive control for FISH 
analyses. Lymphocyte and stromal nuclei from the same tumor were used as normal controls for 
each tumor. In addition, we analyzed six cases of skin punch biopsies from patients without a 
history of germ cell tumors as negative controls.  
 
Results 
A total of 50 cases from 48 neonates, infants, and children (2 recurrent cases from 2 
different patients) were identified. Thirty-four cases were from female (F) patients and 14 from 
male (M) (F: M ratio = 2.4: 1). Patient age ranged from 0 days–8 years (median, 2 weeks). 
Follow up information was available in 30 patients (range: 4–254 months; mean, 8.9 years), and 
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all were alive with no evidence of disease with the exception of one who was alive but disease 
status unknown.  
Among the 48 pediatric patients, there were 44 teratomas and 4 tumors consisting of 
teratoma and yolk sac tumor (1 of which also had primitive neuroectodermal tumor). The 
teratomas included 37 mature teratomas and 11 immature teratomas (4 grade 1, 2 grade 2, and 5 
grade 3). The 44 teratomas lacking a yolk sac tumor component were all negative for i(12p) 
(Figure 1). The 4 tumors with a yolk sac tumor component were all positive for i(12p) (Figure 
2).  
A total of four adult cases from 3 females and 1 male were identified (F: M ratio = 3: 1). 
Patient age ranged from 22–50 years (median, 35 years). Follow up information was available in 
2 patients, and both were alive with no evidence of disease at 82 and 180 months, respectively. 
None of these patients had a documented history of teratoma in childhood, and all cases lacked 
nonteratomatous germ cell tumor components, immature elements, and i(12p).  
Follow up information was, therefore, available for 32 patients. Two patients with 
teratoma had recurrence, but were alive with no evidence of disease after long-term follow up. 
One patient with teratoma and yolk sac tumor had recurrence 7 months after resection. The other 
patients were alive with no evidence of disease at last follow up. 
 A detailed clinicopathologic summary of all 54 cases including their i(12p) status is 
provided in Tables 1 and 2.  
    
Discussion 
Sacrococcygeal teratomas occurring in adults are rare, and there have been limited 
studies on the i(12p) status of sacrococcygeal teratomas, including those with malignant GCT 
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elements. We therefore investigated the i(12p) status of a large series of both prepubertal and 
postpubertal sacrococcygeal teratomas, some including yolk sac tumor and primitive 
neuroectodermal tumor, and correlated the findings with available long-term clinical follow up.   
 The majority (88%) of our sacrococcygeal teratomas occurred in infants (<1 year) with a 
female predominance (F: M = 2.4: 1, or 71% among the pediatric cases). These findings are 
similar to large American,
13
 British,
15
 and Japanese
17
 series of pediatric sacrococcygeal GCT 
cases, in which 74% (of 126 patients), 80% (of 51 patients), and 75% (of 289 patients) were 
girls. There were 35 mature teratomas (lacking a yolk sac tumor component, 73%), 9 immature 
teratomas (lacking another component, 19%), and 4 teratomas with a yolk sac tumor component 
(8%). These findings are similar to those reported in the largest of these series, Yoshida, et al. 
(67% mature teratoma, 16% immature teratoma, and 17% with yolk sac tumor).
17
 
All four pediatric cases with yolk sac tumor (including one which also had a primitive 
neuroectodermal tumor component) displayed i(12p). The other 44 pediatric cases (including 35 
mature teratomas and 9 immature teratomas) lacked i(12p). Three of the 30 pediatric cases with 
follow up (10%) had recurrence, a percentage very similar to the 8.7% reported by Yoshida, et 
al.
17
  
All four adult cases were negative for i(12p) and neither of the 2 patients with follow up 
had recurrence. As a whole, regardless of patient age, the presence of malignant GCT 
components, or i(12p) status, all patients except for one were alive without evidence of disease at 
time of last follow up (mean, 9.4 years).  
The occurrence of teratomas in the sacrococcygeal region, representing approximately 
40% of all teratomas, is not well understood, but may relate to the presence of stem cells. 
Evidence for this includes the expression of the stem cell markers NANOG, OCT4, SSEA-4, and 
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nestin in these tumors as well as the high risk of recurrence if the coccyx (thought to harbor 
associated stem cells) is not removed along with the tumor.
38
 These tumors have been believed to 
arise from the embryonic tail bud,
38
 but the presence of foregut-derived structures such as 
respiratory epithelium has been cited as arguing against this interpretation.
39
  Sacrococcygeal 
teratomas most commonly occur in neonates and infants and studies consistently show a female 
predominance.
11, 13, 15
 The reason for the female predominance has not been determined, but 
might result from later sex-specific differentiation of the caudal mesenchymal tissue including 
the vertebral column and the pelvic skeleton in the embryo.
38
 Occasional examples of these 
tumors have been familial with known or suspected mutations, including patients with Currarino 
Syndrome, thought to involve the HLXB9 gene,
40
 or with other genetic associations such as 
partial trisomy 3q  with Cornelia de Lange Syndrome-like phenotype.
41
 Most of the patients, 
however, do not have a known genetic abnormality.  
The frequency of a malignant component within a sacrococcygeal teratoma is related to 
patient age, with 1.5% of tumors from newborns containing a malignant component compared to 
nearly 40% of tumors from children older than 1 year.
18
 It has been suggested that yolk sac 
tumor may occur in sacrococcygeal teratoma as a form of tumor progression.
42
 This seems to be 
true for the wide variety of somatic tumors that may arise in sacrococcygeal GCTs, including 
recently reported pediatric cases with sarcoma,
43
 nephroblastic elements,
44
 peripheral primitive 
neuroectodermal tumor,
40
 malignant ependymoma component,
45
 neuroblastoma,
46
 and malignant 
steroidogenic tumor
47
 and adult cases with neuroendocrine carcinoma,
48
 adenocarcinoma,
49
 and 
intestinal-type mucinous neoplasm which recurred as disseminated intraperitoneal disease with 
pseudomyxoma peritonei.
50
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Testicular teratomas may be behaviorally and pathogenetically separated into two broad 
groups: prepubertal teratomas with typically benign behavior and postpubertal teratomas that are 
typically components of malignant germ cell tumors. The prepubertal teratomas lack i(12p) 
abnormalities and are therefore thought to arise from germ cells that are cytogenetically normal, 
at least in terms of 12p amplification.
28, 51
 The i(12p) abnormality or other 12p amplification is a 
nearly constant finding in adult testicular GCTs including pure teratoma,
51
; however occasional 
benign postpubertal testicular teratomas lacking 12p amplification exist.
52
 
 Ovarian teratomas without and with nonteratomatous elements similarly appear to 
represent two pathogenetically distinct categories.
36
 Ovarian teratomas lack i(12p) abnormalities, 
even if immature teratoma is present, unless a nonteratomatous germ cell component is 
present.
28, 36
 Ovarian teratoma with associated yolk sac tumor and/or embryonal carcinoma will 
frequently contain i(12p) in both the teratoma and nonteratomatous components.
36
  
   It seems reasonable to speculate that sacrococcygeal teratomas similarly may be divided 
into two pathogenetically distinct categories, but previously few data concerning i(12p) status 
were available. Using classical cytogenetic analysis, no chromosome 12 abnormalities were 
noted in 18 pediatric sacrococcygeal teratomas, including cases with immature teratoma but no 
nonteratomatous component (3 cases) and cases with nonteratomatous components (6 cases).
28
 A 
series of 14 pediatric and 5 adult sacrococcygeal teratomas with i(12p) analysis by FISH was 
recently reported by Gurda, et al.
16
 In that study, tumors with associated malignant germ cell 
tumor (yolk sac tumor) were excluded, but 3 of the pediatric cases had immature elements. 
While recurrence was observed in 3 pediatric cases and 4 adult cases, no mortality was 
documented with a median follow up of 6 years. Thirteen of these cases (9 pediatric and 4 adult) 
had FISH analysis performed and none of the cases had an i(12p) abnormality. 
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 Our findings confirm the absence of i(12p) in both pediatric and adult sacrococcygeal 
teratoma cases, unless an associated malignant GCT component is present.  Only 1 tumor with 
immature teratoma was analyzed for i(12p) in the previous study
16
 and we have confirmed the 
absence of i(12p) in 9 additional cases of teratoma with an immature component but no 
malignant germ cell component.  
 The i(12p) abnormality was not observed in the 4 adult sacrococcygeal teratomas. The 
i(12p) abnormality was detected in 8% (4/44) of pediatric sacrococcygeal germ cell tumors, but 
only in those with a nonteratomatous component. This is similar to the findings in ovarian 
teratomas with and without a nonteratomatous component. These cytogenetic findings suggest 
that pediatric sacrococcygeal teratomas should be considered as two distinct groups, those with 
and those without other components, and that each group has a distinct molecular pathogenesis.  
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Figure Legends 
Figure 1: Mature teratoma with glial (1A), ciliated and enteric-type glandular epithelium (1B), 
and squamous epithelium (1C). FISH analysis (1D) shows two paired red and green signals per 
nucleus, indicating two intact copies of chromosome 12. 
 
Figure 2: Tumor with mature teratoma (2A), immature teratoma (2C), and yolk sac tumor 
components (2E). FISH analysis demonstrates green-red-green signals indicating an i(12p) in the 
mature teratoma (2B), immature teratoma (2D), and yolk sac tumor components (2F). 
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Table 1. Clinicopathologic summary of sacrococcygeal teratomas in both pre- and post-
pubertal patients 
 
Patient Sex Age 
Teratoma 
Grade 
Other GCT i(12p) 
Duration of 
F/U 
(months) 
F/U Status 
Pediatric cases 
1 F 1d 0 None Neg N/A N/A 
2 F 1d 0 None Neg 198 Alive, NED 
3 F 2d 0 None Neg N/A N/A 
4 F 2d 0 None Neg 163 Alive, NED 
5 F 2d 0 None Neg N/A N/A 
6 F 2d 0 None Neg N/A N/A 
7 F 2d 1 None Neg N/A N/A 
8 F 2d 1 None Neg 142 Alive, NED 
9 F 2d 2 None Neg N/A N/A 
10 F 2d 3 
YST and 
PNET 
Pos 136 Alive, NED 
11 F 4d 0 None Neg N/A N/A 
12 F 4d 0 None Neg N/A N/A 
13 F 4d 0 None Neg N/A N/A 
14 F 5d 0 None Neg 77 Alive, NED 
15 F 5d 3 None Neg 21 Alive, NED 
16 F 7d 0 None Neg 140 Alive, NED 
17 F 12d 2 None Neg 59 Alive, NED 
18 F 2w 0 None Neg 136 Alive, NED 
19 F 3w 0 YST Pos 7 Recurred 
20 F 4w 0 None Neg 4 Alive, NED 
21 F 6w 0 None Neg 4 Alive, NED 
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22 F 6w 0 None Neg N/A N/A 
23 F 8w 0 None Neg 48 Alive, NED 
24 F 9w 0 None Neg 90 Alive, NED 
25 F 3m 0 None Neg 243 Alive, NED 
26 F 3m 3 None Neg 199 Alive, NED 
27 F 4m 0 None Neg N/A N/A 
28 F 5m 0 None Neg N/A N/A 
29 F 7m 1 YST Pos 94 Alive, NED 
30 F 1y 0 None Neg - - 
30 F 1y 0 None Neg 188 
Recurred 8 
months later 
but now Alive, 
NED 
31 F 1y 0 None Neg 233 Alive, NED 
32 F 1y 0 None Neg N/A N/A 
33 F 1y 0 YST Pos 15 Alive 
34 F 1y 0 None Neg 52 Alive, NED 
35 M 
16w GA 
fetus 
3 None Neg N/A N/A 
36 M 1d 0 None Neg N/A N/A 
37 M 2d 3 None Neg 228 Alive, NED 
38 M 4d 0 None Neg 81 Alive, NED 
39 M 4d 0 None Neg 254 Alive, NED 
40 M 11d 0 None Neg 59 Alive, NED 
41 M 2w 0 None Neg - - 
41 M 6m 0 None Neg 147 
Recurred after 
6 months but 
now Alive, NED  
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42 M 3w 0 None Neg 139 Alive, NED 
43 M 4w 0 None Neg N/A N/A 
44 M 4w 1 None Neg 35 Alive, NED 
45 M 8m 0 None Neg N/A N/A 
46 M 1y 0 None Neg N/A N/A 
47 M 6y 0 None Neg 77 Alive, NED 
48 M 8y 0 None Neg 95 Alive, NED 
Adult cases 
49 F 35y 0 None Neg 82 Alive, NED 
50 F 35y 0 None Neg N/A N/A 
51 F 50y 0 None Neg 180 Alive, NED 
52 M 22y 0 None Neg N/A N/A 
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Table 2. Summary of 52 patients (54 specimens) with sacrococcygeal teratoma. 
 
 Pediatric patients (48) Adult patients (4) 
Female: Male Ratio 2.4 : 1   3 : 1 
Age 
     Range 
     Median  
 
0-8 years 
2 weeks 
 
22-50 years 
35 years 
Pathology and i(12p) status 
     Teratoma (without YST), 
G0 
     Teratoma (without YST), 
G1 
     Teratoma (without YST), 
G2 
     Teratoma (without YST), 
G3 
     Teratoma and yolk sac 
tumor 
 
35 (0% i(12p)) 
3 (0% i(12p)) 
2 (0% i(12p)) 
4 (0% i(12p)) 
4 (100% i(12p)) 
 
4 (0% i(12p)) 
Outcome 
     No evidence of disease 
     Alive (status unknown) 
     Recurrent  
     Not available 
 
28* 
1 
1 
18 
 
2 
 
 
2 
Mean follow up (range) 8.9 years (4-254 months) 10.9 years (82-180 months) 
 
*Including 2 with recurrence and second excision with NED at 147 and 188 months follow up. 
YST: yolk sac tumor. 
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